activation of Raf-1 (Fabian et al., 1994). Arg89 is contained within the Raf-1 N-terminal regulatory domain in a An interaction with the Ras proto-oncogene product is conserved region that has been defined as the Ras-binding a requirement for Raf-1 activation in many signaling domain (RBD; residues 51-131) (Vojtek et al., 1993; cascades. The significance of this interaction is demon- Scheffler et al., 1994) . Elucidation of the crystal structure strated by the fact that a mutation preventing the Rasof the Raf-1 RBD in complex with the Ras subfamily Raf interaction severely impairs the function of both member Rap1A has revealed that Arg89 forms a direct, mammalian (Raf-1) and Drosophila (D-Raf) Raf prowater-mediated interaction with two amino acid residues teins. In D-Raf, however, dominant intragenic of Rap1A (Nassar et al., 1995) . In addition, studies using mutations have been identified that suppress the effect circular dichroism to analyze the dissociation constant of of the Ras-binding site (RBS) mutation. To address the Ras-Raf interaction have confirmed that the R89L the mechanism by which these mutations restore Raf mutation abrogates the interaction between Ras and Raf-1 signaling, we have introduced the suppressor mutations (Block et al., 1996) . Therefore, both structural and mutainto the analogous residues of mammalian Raf-1. Here, tional analyses have established the importance of Arg89 we show that rather than compensating for the RBS for the binding of Raf-1 to Ras. mutation by restoring the Ras-Raf-1 interaction, the
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In Drosophila Raf (D-Raf), the analogous arginine suppressor mutations increase the enzymatic and bioresidue (Arg217) has also been shown to play a crucial logical activity of Raf-1, allowing Raf-1 to signal in the role in D-Raf-mediated signal transduction. Mutation of absence of Ras binding. Surprisingly, we find that while Arg217 (R217L) markedly alters D-Raf function and one of the suppressor mutations (P181L) increases the causes lethality in hemizygous males (Melnick et al. , basal kinase activity of Raf-1, it also abolishes the 1993). However, dominant intragenic mutations have been ability of wild-type Raf-1 to become activated by identified that suppress the lethality associated with the Ras. This mutation occurs in the cysteine-rich domain Ras-binding site (RBS) Arg217 mutation (Lu et al., 1994) .
(CRD) of Raf-1 and demonstrates the importance of
From this study, four intragenic suppressor mutations were this region for a productive Ras-Raf interaction.
recovered, each containing one compensatory amino acid Finally, we present evidence that the most activating change in either the CR1 (F290I and P308L) or CR3 suppressor mutation (G498S) increases Raf-1 activity (G621S and L733Q) domains of D-Raf. Of the four by introducing a novel phosphorylation site into the residues altered by mutation, three are conserved in all
Introduction
identified important residues involved in Raf function. Therefore, to address whether the D-Raf RBS suppressor The Raf-1 serine-threonine kinase plays an essential role mutations have occurred in key residues that regulate Raf in the transmission of many proliferative, developmental activity and to determine the mechanism by which these and oncogenic signals. Although the exact mechanisms mutations restore Raf signaling, we introduced the anaresponsible for activating Raf-1 in response to signaling logous mutations into mammalian Raf-1 and examined events are not fully understood, a prerequisite for Raf-1 the activities of the resulting mutant proteins. In this activation in many signaling pathways is an interaction study, we find that the suppressor mutations increase the with the Ras proto-oncogene product (reviewed by biological and enzymatic activity of Raf-1 and reveal new Marshall, 1994a; Moodie and Wolfman, 1994; Morrison, mechanisms of Raf-1 activation. 1995). The involvement of Ras in Raf-1 function was first demonstrated by genetic and biochemical studies showing that in many cases the activation of Raf-1 is dependent
Results
on a functional Ras protein (Szeberenyi et al., 1990; Dickson et al., 1992; Troppmair et al., 1992; Wood et al., The RBS suppressor mutations activate the biological and enzymatic activity of Raf-1 1992; Han et al., 1993) . Subsequently, Raf-1 has been shown to interact directly with GTP-bound forms of Ras To determine whether amino acid changes analogous to the D-Raf suppressor mutations would act as suppressors in vitro and in vivo (Finney et al., 1993; Moodie et al., 1993; Van Aelst et al., 1993; Vojtek et al., 1993; of the R89L mutation in mammalian Raf-1, we generated mutant Raf-1 proteins that contained both the R89L mutation and each of the suppressor mutations (F163I, P181L and G498S; Figure 1A ). In addition, to determine the effect that these mutations would have on the activity of wild-type (WT) Raf-1, we also introduced the suppressor mutations into the WT protein. The resulting mutant proteins were then expressed in stage VI-arrested Xenopus oocytes and evaluated for their ability to promote oocyte meiotic maturation [as evidenced by germinal vesical breakdown (GVBD)]. The Xenopus oocyte meiotic maturation assay was chosen for this analysis because it has been previously used to identify other activated mutants of the Ras/Raf-1/MAPK pathway (Birchmeir et al., 1985; Fabian et al., 1993a; Therrien et al., 1996) . In addition, a significant advantage of this assay system is that mutations resulting in subtle changes in the biological and enzymatic activity of Raf-1 can be easily detected. As shown in Figure 1B , expression of R89L Raf-1 was unable to promote oocyte meiotic maturation. However, all of the R89L Raf-1 proteins containing the suppressor mutations (R89L/G498S Raf-1, R89L/F163I Raf-1 and R89L/P181L Raf-1) induced maturation in~20% of the oocytes ( Figure  1B) . Similarly, when the suppressor mutations were introduced into WT Raf-1, an increase in biological activity was observed. While WT Raf-1 induced GVBD in only 4% of the oocytes, F163I Raf-1 promoted maturation in 41%, P181L Raf-1 in 17% and G498S Raf-1 in 85% of the oocytes. Interestingly, although the P181L mutation had an equivalent effect on both the R89L Raf-1 and WT Raf-1 proteins, both the F163I and G498S mutations resulted in a more substantial increase in the activity of WT Raf-1 (41% GVBD for F163I Raf-1 versus 20% for R89L/F163I Raf-1 and 85% GVBD for G498S Raf-1 versus 22% for R89L/G498S Raf-1).
To examine whether the increased biological activity of the mutant proteins correlated with an increase in enzymatic activity, we immunoprecipitated the WT Raf-1 and R89L Raf-1 proteins from oocyte lysates and then measured the kinase activity of the mutant proteins using MEK (also known as MKK1) as an exogenous substrate Raf-1 to the plasma membrane where it becomes activated three injected oocytes and in vitro protein kinase assays were and that artificially targeting Raf-1 to the plasma membrane performed as described in Materials and methods, using MEK as an results in constitutive activation of the kinase (Leevers exogenous substrate. The amount of 32 P incorporated into MEK was then determined. The activity of WT/Raf-1 was expressed as one ; Stokoe et al., 1994) . Since membranethe fold activation for each mutant represents the average of three localized Raf-1 proteins, such as Raf-CAAX, efficiently experiments.
promote the meiotic maturation of Xenopus oocytes, we next investigated the effect of the suppressor mutations on the kinetics with which Raf-CAAX induced oocyte determined at times when WT Raf-CAAX had induced GVBD in 0% (T1), 15% (T2), 40% (T3) and 80% (T4) maturation. WT and mutant Raf-CAAX proteins were expressed in Xenopus oocytes and maturation levels were of the oocytes ( Figure 2 ). Our results indicate that while Fig. 2 . Effect of the RBS suppressor mutations on the biological activity of membrane-localized Raf-1. Xenopus oocytes were injected as described in Figure 1B and the kinetics of GVBD induced by the expression of WT Raf-CAAX, F163I Raf-CAAX, P181L Raf-CAAX, G498S Raf-CAAX or K375M Raf-CAAX was determined. Maturation levels were measured at times when WT/Raf-CAAX had induced GVBD in 0% (T1), 15% (T2), 40% (T3) and 80% (T4) of the oocytes. The results shown are the average of two independent experiments. 30% and 60% faster, respectively, than did WT Raf- subsequently examined by immunoblotting with antibodies to Raf-1 to ensure that equivalent amounts of the Raf-1 proteins were present. In
The RBS suppressor mutations do not restore the comparison with the activity of R89L Raf-1, the fold activation for WT Raf-1 expressed in the presence of Ha-Ras V12 was: 25.3; F163I
Ras-Raf-1 interaction
Raf-1, 22.1; R89/F163I Raf-1, 4.2; P181L/Raf-1, 4.4; R89L/P181L To address the mechanism by which the RBS suppressor Raf-1, 3.8; G498S Raf-1, 41.0 and R89L/G498S Raf-1, 4.8.
mutations have increased Raf-1 activity, we first examined the effect of these mutations on the ability of Raf-1 to interact with Ras. Activated Ha-Ras V12 and each of the To extend these observations, we examined whether the RBS suppressor mutations altered the ability of Raf-1 to WT/Raf-1 and R89L/Raf-1 proteins were coexpressed in Xenopus oocytes. At the time of GVBD, Ras immunoprebe activated by Ha-Ras V12 . Raf-1 proteins were immunoprecipitated from Xenopus oocytes coexpressing activated cipitates were prepared and examined for the presence of Raf-1 by immunoblot analysis. As expected, WT Raf-1 Ha-Ras V12 and each of the WT Raf-1 and R89L Raf-1 proteins, and the enzymatic activity of the immunoprecipiwas detected in the Ras immunoprecipitates, but R89L Raf-1 was not. Likewise, none of the mutant R89L tated proteins was determined (Figure 3 ). Consistent with previous reports from our laboratory (Fabian et al., 1994) , Raf-1 proteins were able to coimmunoprecipitate with HaRas V12 , indicating that the suppressor mutations had not the kinase activity of R89L Raf-1 was very low and unable to be activated by Ha-Ras V12 . The mutant R89L restored the ability of R89L Raf-1 to associate with HaRas V12 . Examination of the WT Raf-1 proteins revealed
Raf-1 proteins all exhibited a kinase activity that was~4-fold higher than that of R89L Raf-1, but this level of that both G498S Raf-1 and WT Raf-1 associated with HaRas V12 to approximately the same extent. However, a activity was equivalent to that observed when the mutant R89L Raf-1 proteins were expressed in the absence of decreased interaction between Ha-Ras V12 and either F163I Raf or P181L Raf-1 was consistently observed, with the Ha-Ras V12 (compare Figures 1C and 3) , indicating that these proteins were unable to be activated by Ha-Ras V12 . reduction being the greatest (Ͼ80%) for P181L/Raf-1. Thus, in the context of WT Raf-1, none of the suppressor When the activity of the WT Raf-1 proteins containing the suppressor mutations was compared with the activities mutations enhanced the association with Ha-Ras V12 and, in fact, two of the mutations inhibited the Ras-Raf-1 of the respective mutant R89L Raf-1 proteins, both the G498S Raf-1 and F163I Raf-1 had increased activity in interaction. Fig. 5 . Effect of the RBS suppressor mutations on the Raf-1/14-3-3 interaction. FLAG epitope-tagged WT Raf-1, R89L Raf-1, F163I Raf-1, R89L/F163I Raf-1, P181L Raf-1, R89L/P181L Raf-1, G498S Raf-1, R89L/G498S Raf-1 and CRM/Raf-1 proteins were transiently expressed in 293 cells. The FLAG antibody was used to immunoprecipitate the tagged Raf-1 proteins from cells lysed in NP-40 lysis buffer. The immunoprecipitates were resolved by electrophoresis on a 10% SDS-polyacrylamide gel and examined by immunoblotting with antibodies to Raf-1 and 14-3-3. (Figure 5) . Therefore, the RBS buffer and in vitro protein kinases were performed using MEK as the suppressor mutations do not appear to enhance the activity exogenous substrate. Assays were terminated by the addition of gel of Raf-1 by altering the Raf-1-14-3-3 interaction.
loading buffer, the samples were resolved by electrophoresis on an 8% SDS-polyacrylamide gel and the phosphoproteins were visualized by autoradiography.
Activation of Raf-1 by a negatively charged aspartic acid residue at the 498 site Examination of the suppressor mutations and the amino response to Ha-Ras V12 , demonstrating that these mutations had not altered the ability of WT Raf-1 to be activated acid context in which they are located reveals that the glycine to serine substitution at the 498 site has generated by Ha-Ras V12 . However, the strong activational effect of Ha-Ras V12 appears to override and partially obscure the a consensus sequence of phosphorylation (RXXS) and hence introduced a potential site of phosphorylation activational effect of the F163I and G498S mutations. Surprisingly, the activity of P181L Raf-1 was equivalent (Pearson and Kemp, 1991) . The 498 residue is contained within the L 12 activation loop of the Raf-1 kinase domain to the activity of R89L/P181L Raf-1 and was not elevated in the presence of Ha-Ras V12 , indicating that the P181L and, for other protein kinases, phosphorylation in this region has been shown to have an activational effect mutation had altered the ability of this protein to be activated by Ha-Ras V12 . This finding was further confirmed (reviewed by Marshall, 1994b) . Thus, to address whether phosphorylation plays a role in enhancing the activity of using the baculovirus/Sf9 cell expression system. When expressed in Sf9 cells, the basal kinase activity of P181L the G498S mutants, we performed further mutational analysis of the 498 site. By site-directed mutagenesis, the Raf-1 was elevated in comparison with WT Raf-1; however, no increase in activity was observed when P181L glycine residue at the 498 site was changed to an alanine residue, which is unable to be phosphorylated; to an Raf-1 was coexpressed with Ha-Ras V12 (Figure 4 ). These findings indicate that not only has the P181L mutation aspartic acid residue, which mimics the negative charge of a phosphorylated residue; and to a threonine or tyrosine inhibited the Ras-Raf-1 interaction but it has rendered the protein unable to be activated by Ha-Ras V12 .
residue, both of which are potential phosphate acceptors. The activity of these mutants was then measured using the Xenopus oocyte maturation assay. As shown in Figure The RBS suppressor mutations do not alter the Raf-1-14-3-3 interaction 6, G498A Raf-1 induced maturation in 23% of the oocytes; G498T, 21%; G498Y, 31% and G498D, 61%. These Another mechanism by which the RBS suppressor mutations could increase Raf activity is to enhance the findings demonstrate that although any perturbation of the 498 site increased the biological activity of Raf-1, the interaction of Raf-1 with an activator molecule or protein.
One such protein that has been proposed to be involved greatest increase was observed with the negatively charged aspartic acid substitution. This result, together with the in the Raf-1 activation process is 14-3-3 (Fantl et al., 1994; Freed et al., 1994; Irie et al., 1994) . Therefore, we finding that the activational effect of phosphorylation in the L12 loop can be recapitulated in MEK kinase by the investigated the effect of the RBS suppressor mutations on the Raf-1-14-3-3 interaction. Human 293 cells were substitution of negatively charged residues (Alessi et al., 1994; Huang and Erickson, 1994; Mansour et al., 1994 , transiently transfected with constructs encoding FLAG epitope-tagged versions of the various WT Raf-1 and 1996) , support the idea that phosphorylation plays a role in the activation of G498S Raf-1. R89L Raf-1 proteins. Forty-eight hours later, the FLAGtagged Raf-1 proteins were immunoprecipitated and examined for the presence of 14-3-3. As a control, cells G498S Raf-1 contains a novel phosphopeptide To determine whether the G498S mutation has indeed were also transfected with a construct expressing a Raf-1 mutant defective in its ability to associate with 14-3-3 resulted in a novel phosphorylation event, we compared the in vivo phosphorylation state of WT Raf-1 and G498S (CRM Raf-1; Michaud et al., 1995) . Results from this experiment indicate that in comparison with WT Raf-1 Raf-1. FLAG-tagged WT Raf-1 and G498S Raf-1 were Raf-1 proteins were then isolated and subjected to twodimensional tryptic phosphopeptide mapping analysis ( Figure 7) . Examination of the WT Raf-1 peptide map mutations on the R89L Raf-1 protein was more subtle than has been observed for other activating Raf-1 mutations revealed two major phosphopeptides representing the phosphorylation of serine residues 259 and 621 (Morrison (Fabian et al., 1993b; Michaud et al., 1995) . However, this result is consistent with the observation that, in et al., 1993). In comparison, the map of G498S Raf-1 contained a novel third phosphopeptide whose migration Drosophila, the suppressor mutations restore R217L D-Raf signaling but do not induce a dominant activated phenotype was consistent with the predicted mobility of the peptide containing the G498S site (based on the charge, mass (Lu et al., 1994) . In the context of WT Raf-1, the suppressor mutations also increased the enzymatic and and hydrophobicity of the peptide; Boyle et al., 1991) . Therefore, the findings that substitution of a negatively biological activity of Raf-1, but the degree to which these mutations altered Raf-1 activity was not equivalent. The charged residue at the 498 site had the greatest activation effect and that the increased activity of G498S Raf-1 G498S mutation was found to be the most activating, followed by the F163I and P181L mutations, respectively. correlates with the presence of a major novel phosphopeptide provide strong evidence that phosphorylation is The observed differences in activation levels may simply reflect some deleterious effect caused by the R89L mutathe mechanism by which the G498S mutation enhances Raf-1 activity.
tion (such as a structural alteration) that cannot be overcome by the suppressor mutations. Alternatively, since the WT Raf-1 proteins are still competent to bind Ras, some Discussion degree of activation may be due to an interaction with the endogenous Xenopus Ras protein that is continually In many signaling pathways, an interaction with Ras is a critical early step in the Raf-1 activation process. For both cycling between the GDP-and GTP-bound states. In this scenario, because Ras binding localizes Raf-1 to the plasma mammalian and Drosophila Raf proteins, an arginine mutation in the Raf RBD severely compromises the ability membrane where it becomes activated, the suppressor mutations would be expected to have a similar effect on of these proteins to mediate cell signaling. However, in Drosophila, the effect of this mutation can be suppressed both WT Raf-1 and membrane-localized Raf-CAAX. This is indeed the case, since the activity of both the WT Raf-1 by several intragenic amino acid substitutions in D-Raf. In this report, the RBS suppressor mutations identified in and Raf-CAAX proteins was most affected by the G498S mutation followed by the F163I mutation. Further support D-Raf were introduced into mammalian Raf-1 and their effect on Raf-1 activity was determined.
for the idea that an interaction with endogenous Ras contributes to the increased activity of the WT Raf-1 Using the Xenopus oocyte maturation assay to measure biological activity, we found that all of the suppressor mutants, comes from the finding that the P181L mutation, which severely inhibits the Ras-Raf-1 interaction and mutations activate Raf-1 (Figure 1 ). When introduced into Raf-1 proteins containing the RBS mutation (R89L Raf), renders WT Raf-1 unable to be activated by Ras, has the same activational effect on both WT Raf-1 and R89L the suppressor mutations resulted in an equivalent increase in activity, with all the mutant R89L Raf-1 proteins Raf-1. Irrespective of the different levels of activation, however, all of the suppressor mutations clearly increase inducing maturation in~20% of the oocytes. In addition, the enzymatic activity of the mutant R89L Raf-1 proteins both the enzymatic and biological activity of Raf-1. In addressing the mechanisms by which the suppressor was elevated 3-to 4-fold above that of WT Raf-1 and R89L Raf-1. The activational effect of the suppressor mutations enhance the activity of Raf-1, we find that none of the mutations restore or increase the Ras-Raf-1 generates a potential site of phosphorylation in a region of the Raf-1 catalytic domain that has been shown to play interaction. In coimmunoprecipitation experiments using proteins expressed in Xenopus oocytes (Figure 3 ), as well a key role in regulating the activity of a number of other kinases (Knighton et al., 1991a,b; Zhang et al., 1994) . as in 293 cells and in Sf9 cells (data not shown), no interaction between activated Ras and any of the R89L This region is called the L 12 activation loop and for several serine-threonine and tyrosine kinases, phosphorylation of Raf-1 proteins was detected. Consistent with these findings, the RBS suppressor mutations have not been found residues within this region results in enzymatic activation (reviewed by Marshall, 1994b) . In addition, for MEK to restore the binding of R217L D-Raf and Drosophila Ras in the two-hybrid interaction system (Hou et al., kinase, substitution of a negatively charged residue within the L 12 loop (which mimics the effect of phosphorylation) 1995; N.Perrimon, personal communication). Furthermore, in the context of WT Raf-1, none of the suppressor results in constitutive activation of the kinase (Alessi et al., 1994; Huang and Erickson, 1994; , mutations enhanced the interaction with Ras and, in fact, the F163I and P181L mutations inhibited the Ras- Raf-1994 Raf- , 1996 . In our studies, we found that when several other amino acid substitutions were made at the 498 site, 1 interaction. Interestingly, both the F163I and P181L mutations are located within the N-terminal cysteine-rich introduction of a negatively charged residue had the greatest activational effect. In addition, the increased domain (CRD) of Raf-1 that has been identified to be a second Ras-binding domain (Brtva et al., 1995; Hu et al., activity of G498S Raf-1 was found to be correlated with the presence of a major, novel phosphopeptide not present 1995; Drugan et al., 1996) . The recent solution structure of CRD reveals that the F163 residue is located in a in WT Raf-1. Together, these results provide strong evidence that phosphorylation plays a role in the activa-β-strand that forms a β-sheet structure while the P181 residue is located at the end of a region that displays an tional effect of the G498S mutation. The RXXS motif generated by the G498S mutation is a consensus site of α-helical character (Mott et al., 1996) . Like the RBD, the CRD is highly conserved and it is likely that the amino phosphorylation for several kinases, such as protein kinase C, cAMP-dependent kinase and Rsk (Hanks and Quinn, acid changes resulting from the P181L and/or F163I suppressor mutations have altered the structure of this 1991). Although we have not addressed which kinase is responsible for phosphorylating G498S Raf-1, the finding domain, decreasing or eliminating its ability to bind or stabilize the interaction with Ras. Other mutations in this that the G498S mutation has the greatest effect on WT Raf-1, which is competent to bind Ras at the plasma region have been shown to reduce the interaction with Ras (Zhang et al., 1993; Chow et al., 1995) ; however, the membrane, and on the membrane-localized Raf-CAAX raises the question of whether the responsible kinase may P181 mutation represents the first report of a single point mutation in the CRD that prevents the Ras-dependent be located at the plasma membrane. Finally, it is interesting to note that the phosphopeptide map of WT Raf-1 activation of Raf-1. This finding, together with previous analyses of the CRD (Brtva et al., 1995; Hu et al., 1995;  expressed in the presence of activated Ha-Ras V12 only contained two major phosphopeptides, representing the Drugan et al., 1996; Mott et al., 1996) , demonstrates the importance of this domain for a productive Ras-Raf phosphorylation of Ser259 and Ser621 (Morrison et al., 1993) . This result appears to suggest that phosphorylation interaction.
It is intriguing that while the F163I and P181L mutations of the L 12 loop does not normally play a role in the Rasdependent activation process. However, our results do inhibit the interaction with Ras, they also increase the enzymatic and biological activity of Raf-1. Our data have not rule out the possibility that under other conditions phosphorylation in this region may contribute to Raf-1 not elucidated the precise mechanism by which these mutations increase Raf activity, but this effect may also regulation.
In conclusion, our study examining the mechanism of be attributed to their location in the CRD. Not only has this region been shown to be involved in Ras binding, it rescue of the D-Raf RBS suppressor mutations has revealed that all of the suppressor mutations increase the enzymatic has also been implicated in the interaction of Raf-1 with other proteins and ligands, such as phosphatidylserine and and biological activity of Raf-1, allowing Raf-1 to signal in the absence of Ras binding. Since the function of Raf 14-3-3 (Ghosh et al., 1994; Michaud et al., 1995) . Our results demonstrate that these mutations do not alter the proteins is highly conserved, it is therefore likely that the suppressor mutations have also resulted in an increase in Raf-1-14-3-3 interaction, although it is possible that the F163I and P181L mutations may enhance the interaction the enzymatic activity of R217L D-Raf, which may account for both the enhanced biological activity and the of Raf-1 with some other activator molecule or reduce the interaction with an inhibitor. Alternatively, it is also suppressor activity associated with these mutations in Drosophila. possible that these mutations have induced structural changes in Raf-1 that increase its enzymatic activity. The N-terminal domain, where the CRD and these mutations
Materials and methods
are located, is thought to function by suppressing the catalytic activity of the kinase domain (Morrison, 1995) .
Antibodies
Thus, in this case, any alteration that reduces the suppressThe Raf-1 antibody used in this study was a mouse monoclonal antibody ive effect of the N-terminal domain would be expected to generated against human Raf-1 (Transduction Laboratories). The FLAG antibody was the M2 mouse monoclonal antibody (Eastman Kodak Co.) increase the activity of Raf-1. Determining which, if either, and the 14-3-3 antibody was a rabbit polyclonal antibody (Santa Cruz of these hypotheses is correct awaits further analysis. Biotechnology, Inc.) . Ras antibodies used in this study include a mouse Our results do, however, indicate that phosphorylation monoclonal antibody generated against the entire 21 kDa human Ras may be the mechanism whereby the G498S suppressor (Ha-Ras) protein (Transduction Laboratories) and the rat monoclonal antibody Y13-238 (Oncogene Science).
mutation increases Raf-1 activity. The G498S mutation
